Soluble Ferric Pyrophosphate: Phase III ongoing

Rockwell said an independent DSMB for the fourth and final time recommended continuation of the double-blind, placebo-controlled Phase III CRUISE-1 & CRUISE-2 trials of SFP. The trials, which complete...